Characteristics of clinical subjects for MRM-MS analysis.

AbbreviationsTACE: Transcatheter arterial chemoembolization.PEIT: Percutaneous ethanol injection therapy.RFA: Radiofrequency ablation.AFP: Alpha-fetoprotein.ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase.CR: Complete Response; PR: Partial Response; SD: Stable disease; PD: Progressive disease.Albumin, Bilirubin, AST, ALT, ALP, and HBV DNA levels data are presented as mean ± SD.aHBV DNA levels were provided for 26 among a total of 35 liver cirrhosis patients, and 29 among the 60 HCC patients.bAntiviral therapy was treatment with Entecavir, Tenofovir, Zeffix, Hepsera and Revovir.cTumor size was provided for 40 among a total of 60 HCC patients.dAccording to American Joint Committee on Cancer (AJCC) staging system (7th edition, 2010).Characteristics of clinical subjects for MRM-MS analysis.